Globus Medical Reports Third Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Globus Medical (GMED) PT Raised to $80 at BofA Securities
November 6, 2024 5:57 AM ESTBofA Securities analyst Craig Bijou raised the price target on Globus Medical (NYSE: GMED) to $80.00 (from $55.00) while maintaining a Underperform rating.
The analyst comments "GMED continues to deliver beat and raises showing that it has managed the NuVasive integration better than... More
Globus Medical (GMED) Tops Q3 EPS by 18c
November 5, 2024 4:24 PM ESTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.83, $0.18 better than the analyst estimate of $0.65. Revenue for the quarter came in at $625.7 million versus the consensus estimate of $604.71 million.
GUIDANCE:
Globus Medical sees FY2024 EPS of $2.90-$3.00, versus the consensus of... More
